Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis

Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositionin...

Full description

Saved in:
Bibliographic Details
Published inCurrent cancer drug targets Vol. 25; no. 5; p. 496
Main Authors Amjadi, Omolbanin, Hedayatizadeh-Omran, Akbar, Zaboli, Ehsan, Janbabaei, Ghasem, Lira, Sergio A, Ahangari, Ghasem
Format Journal Article
LanguageEnglish
Published Netherlands 2025
Subjects
Online AccessGet more information

Cover

Loading…
Abstract Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositioning approach to explore new drug candidates for treating GC. The human GC cell lines AGS, MKN-45, and KATO-III were treated with different concentrations of dopamine, cabergoline, thioridazine, and entacapone to determine effective doses and IC50 values. , cytotoxic activity on cancer cell lines was screened based on dose/time using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) was used to measure the mRNA expression of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and Proliferating Cell Nuclear Antigen (PCNA) in each group. The percentage of apoptotic cells was evaluated using Annexin V/PI staining. Dopamine, cabergoline, thioridazine, and entacapone elicited cytotoxic effects on AGS and KATO-III cells in a dose-dependent manner and elevated the percentage of Annexin Vpositive cells, suggesting the occurrence of apoptosis. The expression of Bcl-2 and PCNA was significantly decreased, whereas the expression of Bax was considerably increased in the AGS and KATO-III cells compared to that in the blank group (p < 0.05); however, no similar effect was observed in MKN-45 cells. Through experiments, this study provides evidence that the antipsychotic drugs cabergoline, dopamine, thioridazine, and entacapone can inhibit gastric cancer growth in AGS and KATO-III cells. These findings suggest that these drugs could be repurposed as novel therapeutic agents for the treatment of gastric cancer.
AbstractList Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however, understanding the shared molecular mechanisms can aid in discovering novel targeted therapies for GC. This study has employed a drug repositioning approach to explore new drug candidates for treating GC. The human GC cell lines AGS, MKN-45, and KATO-III were treated with different concentrations of dopamine, cabergoline, thioridazine, and entacapone to determine effective doses and IC50 values. , cytotoxic activity on cancer cell lines was screened based on dose/time using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) was used to measure the mRNA expression of B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), and Proliferating Cell Nuclear Antigen (PCNA) in each group. The percentage of apoptotic cells was evaluated using Annexin V/PI staining. Dopamine, cabergoline, thioridazine, and entacapone elicited cytotoxic effects on AGS and KATO-III cells in a dose-dependent manner and elevated the percentage of Annexin Vpositive cells, suggesting the occurrence of apoptosis. The expression of Bcl-2 and PCNA was significantly decreased, whereas the expression of Bax was considerably increased in the AGS and KATO-III cells compared to that in the blank group (p < 0.05); however, no similar effect was observed in MKN-45 cells. Through experiments, this study provides evidence that the antipsychotic drugs cabergoline, dopamine, thioridazine, and entacapone can inhibit gastric cancer growth in AGS and KATO-III cells. These findings suggest that these drugs could be repurposed as novel therapeutic agents for the treatment of gastric cancer.
Author Ahangari, Ghasem
Zaboli, Ehsan
Janbabaei, Ghasem
Lira, Sergio A
Amjadi, Omolbanin
Hedayatizadeh-Omran, Akbar
Author_xml – sequence: 1
  givenname: Omolbanin
  orcidid: 0000-0002-1328-6285
  surname: Amjadi
  fullname: Amjadi, Omolbanin
  organization: Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
– sequence: 2
  givenname: Akbar
  orcidid: 0000-0002-9219-883X
  surname: Hedayatizadeh-Omran
  fullname: Hedayatizadeh-Omran, Akbar
  organization: Gastro-intestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran
– sequence: 3
  givenname: Ehsan
  orcidid: 0000-0003-4009-717X
  surname: Zaboli
  fullname: Zaboli, Ehsan
  organization: Department of Internal Medicine, Gastrointestinal Cancer Research Center, Non-Communicable Diseases, Mazandaran University of Medical Sciences, Sari, Iran
– sequence: 4
  givenname: Ghasem
  orcidid: 0000-0003-2651-6200
  surname: Janbabaei
  fullname: Janbabaei, Ghasem
  organization: Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
– sequence: 5
  givenname: Sergio A
  orcidid: 0000-0002-6742-3089
  surname: Lira
  fullname: Lira, Sergio A
  organization: Immunology Institute, Ichan School of Medicine at Mount Sinai, New York, United States
– sequence: 6
  givenname: Ghasem
  orcidid: 0000-0003-1557-4050
  surname: Ahangari
  fullname: Ahangari, Ghasem
  organization: Neuroimmunopsy-chooncogenetic Group, Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, P.O. Box: 1497716316, Tehran, Iran
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38984576$$D View this record in MEDLINE/PubMed
BookMark eNo1UMtKAzEUDaJorf6CZOF2NM9J4q7UWgtFRXRdbjPJdKDNDElG6d_bsbq4nAPnBfcSnYY2OIRuKbljVIl7QqksNSGm5IQLZZggJR2O8vIEjahWvJBSlefogmujxYGO0P7dfTnYNqHGL-4bv8U2dc7m9IAnITdd2ttNmxuLH2NfJ7wIVW9d-tWK3O_aiGfeD34MNTQhZTyHlOMhMIVgXcR5E9u-3hyTw8qka7vcpiZdoTMP2-Su_3CMPp9mH9PnYvk6X0wny2LNKcuFWkuqKmpECd6AVUIbqZWyTHqgnBrjNEjLDAijveAVV4ZUwDkFL4XWjI3RzbG369c7V6262Owg7lf_P2A_w5hfLg
CitedBy_id crossref_primary_10_1016_j_asjsur_2024_12_001
ContentType Journal Article
Copyright Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Copyright_xml – notice: Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.2174/0115680096303479240614061136
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 1873-5576
ExternalDocumentID 38984576
Genre Journal Article
GrantInformation_xml – fundername: National Institute of Genetic Engineering and Biotechnology
  grantid: 772
– fundername: Mazandaran University of Medical Sciences, Iran
  grantid: MAZUMS.13746
GroupedDBID CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-b312t-7b517d1946af9ac74895877c25fa13199e8a5c29a498f43d3790da331af548822
IngestDate Wed May 07 07:47:13 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Dopamine
drug repurposing
gastric cancer
apoptosis
cabergoline
entacapone
thioridazine
Language English
License Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-b312t-7b517d1946af9ac74895877c25fa13199e8a5c29a498f43d3790da331af548822
ORCID 0000-0003-2651-6200
0000-0002-6742-3089
0000-0003-4009-717X
0000-0003-1557-4050
0000-0002-9219-883X
0000-0002-1328-6285
PMID 38984576
ParticipantIDs pubmed_primary_38984576
PublicationCentury 2000
PublicationDate 2025-00-00
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025-00-00
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Current cancer drug targets
PublicationTitleAlternate Curr Cancer Drug Targets
PublicationYear 2025
Score 2.4164279
Snippet Globally, Gastric Cancer (GC) ranks as the fifth leading cause of cancer-related deaths. GC is a multifaceted malignancy with diverse etiologies; however,...
SourceID pubmed
SourceType Index Database
StartPage 496
SubjectTerms Antineoplastic Agents - pharmacology
Antipsychotic Agents - pharmacology
Apoptosis - drug effects
Cell Line, Tumor
Cell Proliferation - drug effects
Drug Repositioning
Humans
Stomach Neoplasms - drug therapy
Stomach Neoplasms - metabolism
Stomach Neoplasms - pathology
Title Revealing New Prospects: Antipsychotic Drugs Induces Anti-tumor Effects against Gastric Cancer through Inducing Apoptosis
URI https://www.ncbi.nlm.nih.gov/pubmed/38984576
Volume 25
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3da5xAEMCXSwshL6Wl31_sQ97E9nRdXft2pNccgTShJBD6EmZ1zZlWPe68QvLX9U_r7IfGHG1o-6CIw56e83OdGWZ2CNnNxFjIOJY-Lxg6KKCED0ko_FjGPOdokgrQAf3Dz_HsNDo442ej0c9B1tK6le-y69_WlfyPVvEc6lVXyf6DZvsfxRN4jPrFPWoY93-l4y_qB9p52tnXaYrHy8bUTa5ssK8tXYVVmXkfl-uLlafbdOgELC3z23XVLL2pS-eACyjRUPT2QffxyLw9DcOy7-JjRpoAyqJZtM2qXA2N2m6Np8wOyvFins0w7w32SXUJuUkcOKqa7xLqsodypnK4wj90Dbma-0fV0oZkJ98k9InDXxFVW8c9nQ-yiA6gliBBGcn-HD_I1TCKEfJBFEPZmVckzOfcNoPppmZbE-0Q5IN5NrJtcDfnf-1fmZoG9EqF9s7wAx0lqbFa9BawW8NQHYvKsIFmm4jcxe-WbqzO3Ym2yBb6Kbrx6vHhNtl19_L-rjvZIdvd6A2fxtg2Jw_JA-eU0Ikl7BEZqfoxuerpokgX7en6QG-xRQ1b1LFFb9iiji3q2KKOLWrZoo4t2rFFe7aekNNP05O9me8adfiSBWHrJ5IHSR6kUQxFCple0IiLJMlCXkCAc3yqBPAsTAFf_SJiOUvScQ6MBVCgw4wm6lNyr25q9ZxQFWXA04iDCmVUiCgdyzCVLGGQCZYE8gV5Zp_U-cKuxnLePcOXf5S8Ijs3yL0m9wt8_dUbtCVb-dYo7BcpdnYS
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revealing+New+Prospects%3A+Antipsychotic+Drugs+Induces+Anti-tumor+Effects+against+Gastric+Cancer+through+Inducing+Apoptosis&rft.jtitle=Current+cancer+drug+targets&rft.au=Amjadi%2C+Omolbanin&rft.au=Hedayatizadeh-Omran%2C+Akbar&rft.au=Zaboli%2C+Ehsan&rft.au=Janbabaei%2C+Ghasem&rft.date=2025-01-01&rft.eissn=1873-5576&rft.volume=25&rft.issue=5&rft.spage=496&rft_id=info:doi/10.2174%2F0115680096303479240614061136&rft_id=info%3Apmid%2F38984576&rft_id=info%3Apmid%2F38984576&rft.externalDocID=38984576